Back to TEVA Stock Lookup

Teva Pharma (TEVA) –

Sep 22, 2016 08:14 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 22
Sep 22, 2016 08:02 AM Teva Pharma's (TEVA) Second Phase III Study of SD-809 in TD Shows Statistically Significant Results
Sep 22, 2016 08:00 AM Teva Announces Positive Top-Line Data from Second Phase III Study of SD-809 in Tardive Dyskinesia (TD)
Sep 20, 2016 09:29 AM Bayer's Dermatology Unit Said to Attract Interest from Teva (TEVA) and Perrigo (PRGO) - Bloomberg
Sep 20, 2016 07:11 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 20
Sep 20, 2016 07:03 AM Regeneron (REGN), Teva Pharma (TEVA) Enter Partnership for Fasinumab Development, Commercialization
Sep 20, 2016 07:00 AM Regeneron and Teva Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
Sep 20, 2016 07:00 AM Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
Sep 19, 2016 07:41 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 19
Sep 19, 2016 07:02 AM Teva Pharma (TEVA) Announces Positive Results from Pridopidine Phase 2 in Huntington Disease
Sep 19, 2016 07:00 AM Teva Announces Results from Exploratory 52-Week Phase 2 PRIDE-HD Study of Pridopidine in Huntington Disease
Sep 16, 2016 07:35 AM Amgen (AMGN): Good AMG334 Migraine Results, But Not Differentiated - Leerink
Sep 15, 2016 09:56 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 15
Sep 15, 2016 09:00 AM Teva Strengthens Injectables Portfolio with the Launch of an Authorized Generic of Cubicin® (Daptomycin for Injection) in the United States
Sep 15, 2016 09:00 AM National Business Group on Health Honors Teva Pharmaceuticals with Best Employers for Healthy Lifestyles® Award
Sep 15, 2016 08:31 AM Drug Stocks on Watch as Bipartisian Bill Expected on Capping Price Increases
Sep 15, 2016 08:00 AM Teva to Develop Unique Wearable Tech and Machine Learning Platform for Continuous Measurement & Analysis of Huntington Disease Symptoms in Collaboration with Intel
Sep 15, 2016 06:44 AM Perrigo (PRGO): Patience Will Be Rewarded - Guggenheim
Sep 12, 2016 07:41 AM Teva Pharma (TEVA): 3 Key Points From Analyst Event - Jefferies
Sep 9, 2016 04:12 PM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 09
Sep 7, 2016 08:15 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 07
Sep 7, 2016 08:00 AM Teva to Present Latest Data in Multiple Sclerosis at 2016 ECTRIMS Congress in London
Sep 6, 2016 08:06 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 06
Sep 6, 2016 08:00 AM Teva to Present at the Wells Fargo 2016 Healthcare Conference
Sep 2, 2016 10:23 AM Notable Analyst Rating Changes 9/2: (TEVA) (PES) (AMFW) Upgraded; (STM) (NVO) (GCO) Downgraded
Sep 2, 2016 10:07 AM Oppenheimer Upgrades Teva (TEVA) to Outperform as Investors to Refocus on Growth
Sep 1, 2016 03:14 PM Mylan (MYL) Receives Favorable PTO Verdict for Third Copaxone IPR (TEVA)
Sep 1, 2016 02:51 PM UPDATE: Teva's (TEVA) '302 Capaxone Patent Invalidated by U.S. Patent Office
Aug 31, 2016 07:18 AM Why Teva Pharma (TEVA) Should Settle With Novartis - Leerink
Aug 30, 2016 07:18 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Aug 30
Aug 30, 2016 07:00 AM Teva to Present New Respiratory Data at the 2016 European Respiratory Society (ERS) International Congress
Aug 29, 2016 01:15 PM Congress Letter to FDA Questioning Generic EpiPen Alternatives (MYL) (TEVA) (ADMP) (IPXL)
Aug 29, 2016 11:58 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Aug 29
Aug 29, 2016 11:50 AM Teva to Host Generic Medicines Business Overview on September 9, 2016
Aug 25, 2016 12:27 PM Teva Pharma (TEVA) PT Lowered to $64 at Mizuho; 'Buy' Maintained
Aug 25, 2016 07:49 AM No Read Through to Biogen (BIIB) from Teva (TEVA) Copaxone IPR Result - Jefferies
Aug 25, 2016 06:51 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Aug 25
Aug 25, 2016 05:02 AM Stocks with Implied Volatility Movement
Aug 24, 2016 05:47 PM Teva Pharma (TEVA) to Appeal PTAB's Decisions on Two COPAXONE Patents
Aug 24, 2016 05:46 PM Teva Confirms PTAB’s Decisions on Two Patents in IPR Challenge to COPAXONE® 40 mg
Aug 24, 2016 04:48 PM Mylan (MYL) Affirms Favorable USPTO Ruling to Invalidate Two Teva Patents Covering Copaxone
Aug 24, 2016 03:42 PM Teva (TEVA) calls active after patent board says certain claims of Copaxone patent invalid
Aug 24, 2016 03:41 PM Teva (TEVA) Patent '413 on Capaxone Also Invalidated by U.S.
Aug 24, 2016 03:25 PM Momenta Phama (MNTA), Teva (TEVA) Active as '250 Patent on Capoxone Invalid
Aug 24, 2016 01:26 PM Impax Laboratories (IPXL) and Teva Pharma (TEVA) Seen as Beneficiaries of Mylan's (MYL) EpiPen Woes - RBC
Aug 24, 2016 04:45 AM Stocks with Implied Volatility Movement
Aug 23, 2016 04:59 AM Stocks with Implied Volatility Movement
Aug 18, 2016 07:18 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Aug 18
Aug 18, 2016 06:18 AM Teva Pharma (TEVA) Gains EC Marketing Approval for CINQAERO
Aug 18, 2016 03:00 AM European Commission Grants Marketing Authorization for Teva’s CINQAERO® (reslizumab)

Back to TEVA Stock Lookup